Division of Mallinckrodt PLC
Latest From BioVectra Inc.
Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Medical Devices, and Pharmaceuticals – and then categorized by type –Acquisition, Alliance, or Financing.
- Nanotechnology, Chips, etc.
- Synthesis Technologies, Production Processes
- Large Molecule
- Contract Research, Toxicology Testing-CRO
- Therapeutic Areas
- North America
- Parent & Subsidiaries
- Mallinckrodt PLC
- Senior Management
Oliver Technow, Pres.
Marc Sauer, PhD, VP, R&D
George Rowat, VP, Fin. & Admin.
Heather Delage, VP, Bus. Dev. & Gen. Mgr.
- Contact Info
Phone: (902) 566-9116
11 Aviation Ave.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.